Melbourne, Australia The Government has expanded access to GSK's shingles vaccine, Shingrix, to cover individuals aged 18 ...

Co-administration of the RSV and shingles adjuvanted vaccines was well tolerated, with acceptable reactogenicity and safety ...

GSK plc (NYSE:GSK) released topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, ...

This population-based study investigated the risk of having had prior herpes zoster within five years preceding a diagnosis of head and neck cancer. We conducted a case-control study that included ...

PHN is characterised by pain lasting from three months to several years after the rash subsides, and it is also the most ...

A man in Saudi Arabia diagnosed with shingles suffered a rare and potentially life-threatening infection that ate away the ...

Additionally, Dr. Brangman says that the Tdap vaccine, which protects against tetanus, diphtheria and whooping cough, is also ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

GSK plc (LSE/NYSE: GSK) is partnering with Brooke Shields, as part of its THRIVE@50+ campaign, to encourage people 50 and ...

The incidence of herpes zoster was 5.4 cases vs. 11.1 cases per 1000 person-years in the vaccinated versus placebo groups, and the incidence of postherpetic neuralgia was 0.5 cases vs. 1.4 cases ...

Bristol Myers Squibb today announced new data from the Phase 3 DAYBREAK trial demonstrating that decreased rates of brain volume loss were sustained in the open-label extension (OLE) for patients ...

Mpox transmits through close physical contact, including sexual contact. There is no evidence that it spreads easily through ...